Stroke-Ready Hospitals Can Save Thousands of Lives Every Year, Indian Stroke Association Steps Up Awareness and Training

IMT News Desk
IMT News Desk
· 3 min read
Indian Stroke Association intensifies awareness and doctor training to help stroke-ready hospitals save lives and reduce disability.

Stroke has become one of India’s fastest-growing medical emergencies, affecting more than 1.8 million people each year and leaving thousands with lifelong disabilities. Experts say the biggest challenge is not the lack of treatment, but the delay in recognising symptoms and reaching a stroke-ready hospital in time.

Doctors stress that every minute matters during a stroke, with nearly 1.9 million brain cells lost each minute. Reaching the hospital within the “golden window” of up to 24 hours can significantly improve recovery and reduce the risk of paralysis, speech problems and long-term disability. Yet many patients lose precious time because early warning signs are mistaken for weakness, fatigue or dizziness.

A stroke-ready hospital is equipped with trained emergency teams, neurologists, CT and MRI imaging, clot-busting medicines that can be administered within 4.5 hours, and advanced procedures, such as mechanical thrombectomy for eligible patients, within 24 hours. These hospitals follow internationally accepted stroke protocols that allow rapid diagnosis and treatment from the moment a patient arrives in the emergency department.

Studies show that patients treated at dedicated stroke-ready centres have better survival rates, lower disability and faster recovery than those who reach hospitals without specialised stroke care. Experts say the first few hours after symptom onset often decide whether a patient can return to independent life or faces permanent disability.

Recognising this urgent need, the Indian Stroke Association (ISA) has intensified nationwide efforts to improve stroke awareness among both the public and healthcare professionals. Through continuing medical education programmes, workshops, conferences, hospital accreditation initiatives, public campaigns and community outreach activities, ISA is working to train doctors, emergency teams, nurses and citizens to identify stroke early and refer patients without delay.

The association is also promoting the B.E.F.A.S.T. approach- Balance loss, Eye problems, Face drooping, Arm weakness, Speech difficulty and Time to reach a hospital immediately- to help ordinary citizens recognise stroke symptoms quickly. Across multiple states, ISA has been working with hospitals, medical colleges, healthcare institutions and government bodies to strengthen stroke referral pathways and improve timely, evidence-based care.

Speaking on the importance of early intervention, Dr. Vikram Huded, Senior Intervention Neurologist and President, Indian Stroke Association (ISA), said, “Stroke is not merely a neurological disease; it is a race against time. Every minute lost results in irreversible brain damage. Our mission is to ensure that every Indian understands the warning signs of stroke and reaches a stroke-ready hospital without delay. Through public awareness campaigns, hospital accreditation, and continuous medical education, ISA is committed to strengthening India’s stroke care ecosystem so that more patients survive with a better quality of life.”

Dr. Arvind Sharma, Senior Neurologist, stroke specialist and Secretary of the Indian Stroke Association (ISA), added, “Many stroke patients can recover remarkably well if they receive treatment within the golden treatment window. Unfortunately, delayed recognition remains one of the biggest barriers in India. Our continuous training programmes for local physicians, emergency doctors, healthcare workers, and hospital teams aim to create a stronger referral network where stroke is identified immediately and patients are transferred rapidly to stroke-ready hospitals. Public awareness and professional education together can save thousands of lives every year.”

The ISA’s nationwide push highlights a simple but urgent message: stroke is a medical emergency, and faster recognition, faster referral and faster treatment can change outcomes dramatically. With stronger awareness and more stroke-ready hospitals, India could save thousands of lives and reduce long-term disability on a major scale.

Read Next

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care
News
July 17, 2026

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care

Menthra, an AI-powered emotional wellbeing platform, today announced the launch of Menthra Care in India, expanding its platform to connect users with verified therapists, coaches, licensed clinical professionals and care organisations when they need support beyond an AI companion. The launch follows Menthra’s India debut in June, which saw tens of thousands of users join […]
Article by: IMT News Desk
IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care
News
July 17, 2026

IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care

Against a backdrop of geopolitical uncertainty, supply chain disruptions and rapid advances in artificial intelligence (AI) and precision medicine, FutureHealth.Now provided a platform for industry leaders to explore how innovation, technology and new models of care can help tackle rising healthcare costs, workforce pressures and growing demand for services across the region. At his opening […]
Article by: IMT News Desk
Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk